BMI alone doesn't tell the whole story of heart failure risk. A large UK Biobank study of nearly 400,000 people found that individuals whose inflammation markers or blood sugar levels were higher than expected for their BMI faced dramatically elevated heart failure risk — up to twice as high in women. Conversely, those with unexpectedly adverse lipid profiles showed lower risk than predicted. This challenges the idea that body weight is the primary driver of cardiovascular danger and suggests that metabolic phenotyping — looking beyond BMI to specific biomarkers — could help identify who truly needs aggressive heart failure prevention. The findings point toward more personalized, precision-based risk stratification rather than relying on weight alone.
